Reaction
Herpes Zoster Meningoencephalitis reporting signals
As of the last recalculation, Herpes Zoster Meningoencephalitis appears in 356 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is SIROLIMUS (PRR 82.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Sirolimus | 18 | 82.2 | 82.3 |
| Alemtuzumab | 19 | 60.6 | 60.7 |
| Moxifloxacin | 13 | 56.0 | 56.0 |
| Amikacin | 14 | 49.9 | 49.9 |
| Isoniazid | 13 | 48.7 | 48.7 |
| Pegaspargase | 8 | 39.1 | 39.1 |
| Mycophenilic Acid | 13 | 38.0 | 38.1 |
| Baricitinib | 6 | 37.0 | 37.0 |
| Linezolid | 15 | 30.7 | 30.7 |